More research focused on the function of ACE2 as the SARS-CoV-2 receptor and proved the binding of SARS-CoV-2 to ACE2 lead to driving the systemic manifestations of COVID-19, including respiratory clinical feature and cardiovascular complication (19). This evidence concerns the gene ACE2 and COVID-19.